[1] Bin, L.Z.; Yi, H.; Xin, Z.G.; He, S. Drug Evaluation Res. 2011, 34, 1-7. [2] Yong, Z.; Yan, L.W.; Zhi, Q.M. J. Chin. Pharm. Sci. 2013, 22, 40-46. [3] Xing, X.Y.; Yan, L.Z.; Xiao, X.Z. J. Chin. Pharm. Sci. 2011, 20, 20-25. [4] China Pharmacopoeia Committee. Pharmacopoeia of the People’s Republic of China. VolⅠ, Beijing: China Chemical Industry Press. 2010, 341. [5] China Pharmacopoeia Committee. Pharmacopoeia of the People’s Republic of China English Edition. VolⅠ, Beijing: China Chemical Industry Press. 2010, 76. [6] Bilia, A.R. Eur. J. Integr. Med. 2012, 4, 108-109. [7] Johnson, M.; Mariswamy, Y.; Gnaraj, W.E. Asian Pac. J. Trop. Biomed. 2011, 1, 428-433. [8] The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Validation of analytical procedures: Text and Methodology Q2 (R1). 2005, http://www.emea.europa.eu/htms/human/ich/background.htm [9] Niklas, J.; Marcus, D.; Bernt, N. J. Chromatogr. A. 2005, 1099, 157-166. [10] Sanz, M.B.; Sarabia, L.A.; Herrero, A.; Ortiz, M.C. Talanta. 2002, 56, 1039-1048. [11] European Pharmacopoeia Committee. European pharmacopoeia-7th Edition. European Directorate for Quality Medicines. 2010, 2.9.12. [12] European Pharmacopoeia Committee.European pharmacopoeia-7th Edition. European Directorate for Quality Medicines. 2010, 2.2.32. [13] European Pharmacopoeia Committee.European pharmacopoeia-7th Edition.European Directorate for Quality Medicines.2010, 2.4.16. [14] European Pharmacopoeia Committee.European pharmacopoeia-7th Edition.European Directorate for Quality Medicines. 2010, 2.8.1. [15] Bieke, D.; Yvan, V.H. J. Chromatogr. A. 2007, 1158, 138-157. |